...
首页> 外文期刊>Pakistan journal of medical sciences. >A comparison study on the clinical effects of foscarnet sodium injection and interferon on human immunodeficiency virus-infected patients complicated with herpes zoster
【24h】

A comparison study on the clinical effects of foscarnet sodium injection and interferon on human immunodeficiency virus-infected patients complicated with herpes zoster

机译:Foscarnet钠注射率和干扰素对人免疫缺陷病毒感染患者的临床疗效的比较研究

获取原文

摘要

Objective: To compare the clinical effects of foscarnet sodium injection and interferon on human immunodeficiency virus (HIV)-infected patients complicated with herpes zoster.Methods: Ninety HIV-infected patients complicated with herpes zoster were divided into a treatment group and a control group that were both treated routinely first. Then the control group and treatment group were administered with interferon and foscarnet sodium injection respectively for four consecutive weeks.Results: After four weeks, the effective rates of the treatment and control groups were 95.6% and 80.0% respectively, which were significantly different (P < 0.05). The pain scores of the two groups were similar before treatment, but the scores of the treatment group were significantly lower than those of the control group two and four weeks after treatment (P < 0.05) as well as were significantly lower than those before treatment (P < 0.05). The numbers of CD4+ cells and the contents of IL-2 of both groups two and four weeks after treatment significantly exceeded those before treatment (P < 0.05), with significant inter-group differences also (P < 0.05). Two and four weeks after treatment, the treatment group scored significantly higher in physical activity, energy, sleep, social life and emotional reaction than the control group did (P < 0.05).Conclusions: HIV-infected patients are prone to being complicated with herpes zoster. Compared with interferon, foscarnet sodium injection better improves the clinical outcomes by effectively relieving pain and by regulating immune mediated inflammatory diseases, thus boosting the prognostic quality of life.doi: http://dx.doi.org/10.12669/pjms.312.6536How to cite this:Qu YY, Pu XM, Kang XJ, An CX. A comparison study on the clinical effects of foscarnet sodium injection and interferon on human immunodeficiency virus-infected patients complicated with herpes zoster. Pak J Med Sci 2015;31(2):309-313. doi: http://dx.doi.org/10.12669/pjms.312.6536This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
机译:目的:比较Foscarnet钠注射率和干扰素对人免疫缺陷病毒(HIV)的临床影响 - 患有疱疹的疱疹病毒(HIV)。方法:九十艾滋病毒感染的患者将疱疹疱疹疱疹疱疹分为治疗组和对照组两者都经常治疗。然后将对照组和治疗组分别用干扰素和福科纳纳钠注射进行连续四个周。结果:四周后,治疗和对照组的有效率分别为95.6%和80.0%,显着不同(P <0.05)。治疗前两组的疼痛评分相似,但治疗组的分数明显低于治疗后两年和四周的对照组(P <0.05),以及显着低于治疗前的对照组( P <0.05)。治疗前两组和两组两组的CD4 +细胞的数量和IL-2的含量显着超过治疗前(P <0.05),具有显着的组间差异(P <0.05)。治疗后两到四周,治疗组的身体活动均显着越高,能量,睡眠,社会生活和情绪反应明显高于对照组(P <0.05)。结论:艾滋病毒感染的患者易于疱疹复杂化带状。与干扰素相比,Foscarnet钠注射钠通过有效缓解疼痛和通过调节免疫介导的炎性疾病,更好地改善了临床结果,从而提高了预后的寿命。:http://dx.doi.org/10.12669/pjms.312.6536How引用这个:quyy,pu xm,kang xj,cx。在膦酸钠注射液的临床效果和干扰素对并发带状疱疹人类免疫缺陷病毒感染患者的比较研究。 Pak J Med Sci 2015; 31(2):309-313。 DOI:http://dx.doi.org/10.12669/pjms.312.6536这是一个在Creative Commons归因许可(http://creativecommons.org/licenses/by/3.0)下分发的开放式访问文章,哪个只要正确引用原始工作,允许在任何媒体中不受限制使用,分发和再现。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号